<DOC>
	<DOCNO>NCT01539148</DOCNO>
	<brief_summary>The investigator look patient diagnosed stage 1-4 cancer enroll five year Quality Life clinical trial study participant previously elect use Insulin Potentiation Targeted Low Dose ( IPTLD ) mean treat illness . This study quality life study treatment study . Participants participate study ask complete quality life questionnaire . The questionnaire complete patient measure mood , energy level , ability function , level pain , measure indicate patient feel quality daily living .</brief_summary>
	<brief_title>A Five-Year Quality Life Study Cancer Patients</brief_title>
	<detailed_description>Patients complete survey per month participation quality life study , series follow-up survey : every two month second year ; every three ( 3 ) month third year every six month fourth fifth year .</detailed_description>
	<criteria>Only patient active treatment IPTLD eligible i.e . patient consent treatment IPTLD . Women pregnant , could become pregnant , may participate study . Patients 18 year age old Patients able willing complete various QoL instrument , give upon enrollment designate followup interval . Patients must either benefit standard , appropriate therapy fail , refuse receive therapy inform standard care particular stage diagnosis . This criterion include ethical , clinical reason . In addition , criterion may develop specifically address : The type , stage , location cancer/metastasis . The length time since diagnosis . Previous treatment attempt outcome , Length time since last treatment concurrent conventional treatment . Nutritional approach , cam treatment , factor may confound study result . Ability , commitment patient follow IPTLD protocol Best Answer Cancer Foundation Kotsanis Institute intend draw subject within pool patient elect undergo IPTLD nutrition therapy treatment choice ; limit universe subject IPTLD patient remove confound effect patient treatment choice possible consideration treatment arm design . The focus simple : follow IPTLD patient determine longitudinal impact treatment quality life experience IPTLD patient treatment group . It allow comparison welldocumented QoL result conventional chemotherapy . This original intent , recruitment effort participant remain within IPTLD patient . The initial , baseline QoL test IPTLD patient choose study include question design elicit reason patient decide IPTLD nutrition therapy . Documenting choice serve two purpose ; correlation reason , attitude reveal factor know impact QoL , positive sense control one 's health choice , drawn . Further , factor account , inference extent IPTLD nutrition therapy responsible impact QoL derive . The Medical Director/Principal Investigator consider exclude specific cancer , ethical reason , intractable know rapid course , know unresponsive IPTLD .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Quality Life</keyword>
	<keyword>Qol</keyword>
	<keyword>Questionnaire</keyword>
	<keyword>Survey</keyword>
	<keyword>Insulin Potentiation Targeted Low Dose Chemotherapy</keyword>
	<keyword>IPTLD</keyword>
	<keyword>Nutritional Therapy</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Cancer Treatment</keyword>
	<keyword>Kotsanis Institute</keyword>
	<keyword>The Best Answer Cancer Foundation</keyword>
	<keyword>Liberty IRB</keyword>
	<keyword>Texas</keyword>
</DOC>